America’s Health Care System is Broken: What Went Wrong and How We Can Fix It. Part 4: The Pharmaceutical Industry
- 1 September 2019
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 132 (9) , 1013-1016
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 DiabetesJAMA, 2019
- Open-Label Study of the Stability of Sublingual Nitroglycerin Tablets in Simulated Real-Life ConditionsThe American Journal of Cardiology, 2018
- Prices For Cardiac Implant Devices May Be Up To Six Times Higher In The US Than In Some European CountriesHealth Affairs, 2018
- Medicare Spending on Brand-name Combination Medications vs Their Generic ConstituentsJAMA, 2018
- Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After ApprovalJAMA Internal Medicine, 2017
- Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare BeneficiariesJAMA Internal Medicine, 2016
- Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesBlood, 2016